Skip to main content
European Commission logo print header

Magnetic Nanohybrids for Cancer Therapy

Projektbeschreibung

Zusammenarbeit für Nanopartikel in der Krebstherapie

Nanotechnologie, die Erforschung extrem kleiner Partikel, bietet in der medizinischen Forschung immenses Anwendungspotenzial. Eisenoxid-Nanopartikel werden bei der Behandlung, Diagnose und Operation von Krebs schon in der nahen Zukunft eine zentrale Rolle spielen. Das Projekt MaNaCa schafft eine Grundlage für die Forschung und die wissenschaftliche und technologische Effizienz. Die Armenische Akademie der Wissenschaften (IPR-NAS) wird dazu mit der Aristoteles-Universität Thessaloniki in Griechenland und der Universität Duisburg-Essen zusammenarbeiten. Allen dreien wird für drei Jahre das Beratungsunternehmen Intelligentsia Consultants Sarl beim Thema magnetische Nanohybride für den Einsatz in der Krebstherapie zur Seite stehen.

Ziel

The MaNaCa project intends to develop the scientific and technological capacity as well as raising the research profile of the Institute for Physical Research of the National Academy of Sciences (IPR-NAS) in Armenia. From a scientific standpoint, MaNaCa will focus on the structural and magnetic characterization of magnetic nanohybrids and their application for cancer therapy. The project's aim will be accomplished by networking IPR-NAS with two internationally-leading research organisations: the Aristotle University of Thessaloniki (AUTH) in Greece and the University of Duisburg – Essen (UDE) in Germany. Throughout the project, the research partners will be supported for management ad dissemination by Intelligentsia Consultants Sàrl (INT), a consultancy company based in Luxembourg which has already collaborated on several occasions with the Widening partner. During the project, which will have a total duration of three years, the partners will carry out a research and innovation strategy with these objectives:

1. Stimulating scientific excellence and innovation capacity of IPR-NAS with regard to magnetic nanohybrids for cancer therapy.
2. Improve the career prospects of early stage researchers of IPR-NAS and the Twinning partners
3. Raise the research profile of IPR-NAS and the Twinning Partners

In order to accomplish this task, the consortium partners will implement several actions through the project’s work packages: (WP1) exchange of senior researchers; (WP2) exchange of early stage researchers; and (WP3) dissemination and oureach. Project management (WP4) will be coordinated by IPR-NAS with the support of INT. In addition to staff exchanges, project's activities will include technical training, joint publications, joint participation to conferences, organization of summer schools, workshops and an international conference.

Programm/Programme

Aufforderung zur Vorschlagseinreichung

H2020-WIDESPREAD-2018-2020

Andere Projekte für diesen Aufruf anzeigen

Unterauftrag

H2020-WIDESPREAD-2018-03

Koordinator

INSTITUTE FOR PHYSICAL RESEARCH OF NATIONAL ACADEMY OF SCIENCES OF ARMENIA
Netto-EU-Beitrag
€ 356 662,50
Weitere Finanzmittel
€ 0,00

Beteiligte (3)